title: Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.
abstract: Cardiac hypertrophy has been well-characterized at the level of transcription. During cardiac hypertrophy, genes normally expressed primarily during fetal heart development are re-expressed, and this fetal gene program is believed to be a critical component of the hypertrophic process. Recently, alternative splicing of mRNA transcripts has been shown to be temporally regulated during heart development, leading us to consider whether fetal patterns of splicing also reappear during hypertrophy. We hypothesized that patterns of alternative splicing occurring during heart development are recapitulated during cardiac hypertrophy. Here we present a study of isoform expression during pressure-overload cardiac hypertrophy induced by 10 days of transverse aortic constriction (TAC) in rats and in developing fetal rat hearts compared to sham-operated adult rat hearts, using high-throughput sequencing of poly(A) tail mRNA. We find a striking degree of overlap between the isoforms expressed differentially in fetal and pressure-overloaded hearts compared to control: forty-four percent of the isoforms with significantly altered expression in TAC hearts are also expressed at significantly different levels in fetal hearts compared to control (P<0.001). The isoforms that are shared between hypertrophy and fetal heart development are significantly enriched for genes involved in cytoskeletal organization, RNA processing, developmental processes, and metabolic enzymes. Our data strongly support the concept that mRNA splicing patterns normally associated with heart development recur as part of the hypertrophic response to pressure overload. These findings suggest that cardiac hypertrophy shares post-transcriptional as well as transcriptional regulatory mechanisms with fetal heart development.
authors.affiliation: Department of Biomedical Engineering, University of Virginia, Health System Box 800759, Charlottesville, VA 22908, USA. ega2d@virginia.edu
authors.forename: E G
authors.initials: EG
authors.lastname: Ames
authors.forename: M J
authors.initials: MJ
authors.lastname: Lawson
authors.forename: A J
authors.initials: AJ
authors.lastname: Mackey
authors.forename: J W
authors.initials: JW
authors.lastname: Holmes
mesh_terms: D017398:Alternative Splicing / Q000235:genetics; D000818:Animals; D006332:Cardiomegaly / Q000235:genetics*; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006321:Heart / Q000196:embryology*; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D012326:RNA Splicing / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017423:Sequence Analysis, RNA
chemical_list: D012333:RNA, Messenger
keywords: Alternative splicing; Cardiac hypertrophy; Heart development; RNAseq